INTRODUCTION {#S1}
============

The Mre11-Rad50-Xrs2 (MRX) complex plays a central role in the DNA damage response through detection and repair of cytotoxic DNA double-strand breaks (DSBs). Mutation of genes encoding the MRX complex in *Saccharomyces cerevisiae* causes genotoxin sensitivity, shortening of telomeres, and meiotic defects ([@R4]; [@R19]). Hypomorphic mutations of human MRX/N (Nbs1 replaces Xrs2 in human cells) complex components result in the chromosome instability syndromes, Nijmegen breakage syndrome (NBS), NBS-like disease (NBSLD), and ataxia telangiectasia-like disease (ATLD), which are associated with radiosensitivity, cancer predisposition, and immunodeficiencies ([@R5]; [@R60]; [@R72]). The cellular phenotype of NBS and ATLD is similar to A-T, which is caused by loss of the AT mutated (ATM) kinase ([@R56]). In contrast to yeast, the mammalian MRN complex is essential for cell viability ([@R61]).

MRX/N is rapidly recruited to DSBs, where it tethers DNA ends and activates the Tel1/ATM kinase to signal the DNA damage checkpoint ([@R61]).Inaddition to the signaling role in response to DSBs, recruitment and activation of Tel1 by MRX at telomeres is necessary for telomere elongation ([@R51]). Moreover, the complex participates in both of the major DSB repair mechanisms: non-homologous end joining (NHEJ) and homologous recombination (HR). For NHEJ, MRX recruits factors necessary for direct re-ligation of the broken ends ([@R9]; [@R39]; [@R48]). For HR, the complex uses its nuclease activity to catalyze degradation of the 5^′^-terminated strands of the break ends to yield single-stranded DNA (ssDNA), the substrate for Rad51 recombinase ([@R65]). MRX/N associates with unperturbed replication forks and stabilizes stalled forks during replication stress ([@R14]; [@R41]; [@R57]; [@R66]). Loss of MRX results in extreme sensitivity to hydroxyurea(HU), loss of replisome components from stalled replication forks, and impaired fork progression in the presence of HU ([@R55];[@R66]).

Mre11 and Rad50 are conserved in all domains of life, whereas Xrs2/Nbs1 appears to be restricted to eukaryotes ([@R61]). Mre11 has ssDNA endonuclease and 3^′^--5^′^ double-stranded DNA (dsDNA) exonuclease activities *in vitro* that are important for end resection. Rad50 is a member of the structural maintenance of chromosome (SMC) family of proteins, characterized by ATPase motifs at the N and C termini separated by a long coiled-coil domain ([@R61]). The globular DNA binding domain of the MRX complex comprises an Mre11 dimer associated with the ATPase cassettes of a Rad50 dimer. ATP binding and hydrolysis regulate access of Mre11 to DNA, thereby controlling the nuclease activity ([@R13]; [@R29]; [@R33]; [@R42]). The extended coiled-coil domains of Rad50 and Zn-mediated dimerization of the hook domains at the apex of the coiled coils are thought to be important to tether DNA ends at DSBs and for sister chromatid interactions ([@R22]; [@R67]; [@R75]). Maintaining close proximity of DNA ends may promote NHEJ by stimulating ligation ([@R9]), while bridging sister chromatids at DSBs facilitates the homology search during HR and prevents the damaged chromatid from physically separating from the rest of the chromosome. Consistent with this view, the integrity of the coiled-coil and Rad50 hook domains are crucial to prevent a DSB from becoming a chromosome break ([@R22]; [@R37]; [@R75]).

Xrs2/Nbs1 is the least conserved member of the complex and is associated with eukaryotic-specific functions, such as telomere maintenance and DNA damage signaling. Xrs2/Nbs1 interacts with phosphorylated Lif1/Xrcc4 and Sae2/CtIP via the forkhead-associated FHA domain at the N terminus ([@R32]; [@R36]; [@R39]; [@R48]; [@R74]) and with Mre11 and Tel1/ATM through conserved motifs in the C-terminal region of the protein ([@R15]; [@R27]; [@R34]; [@R46]; [@R69]; [@R76]). Eukaryotic Mre11 homologs have a large loop insertion within the phosphodiesterase domain, referred to as the latching loop, which mediates interaction with Xrs2/Nbs1 ([@R49]; [@R54]). Nbs1 binding to the latching loops extends the Mre11 dimer interface and stabilizes the dimeric form, suggesting that Xrs2 has an active role in the architecture of the MR complex in addition to its role in checkpoint signaling ([@R54]). Expression of just a 108-amino acid (aa) fragment of murine Nbs1, encompassing the Mre11 interaction domain, is sufficient to sustain cell viability ([@R27]). Xrs2/Nbs1 is the only component of the complex harboring a nuclear localization signal (NLS), and its interaction with Mre11 is necessary for translocation of MRX into the nucleus ([@R5]; [@R12]; [@R69]).

Previous studies have shown that fusing Mre11 to an NLS (Mre11-NLS) partially suppresses the slow growth and DNA damage sensitivity of Xrs2-deficient cells by restoring Mre11 nuclease and Sae2-dependent end resection ([@R47]; [@R69]); however, NHEJ and Tel1 activation are not restored, highlighting the role of Xrs2 as an Mre11 chaperone and scaffold protein, recruiting factors necessary for these functions ([@R47]). The goal of the present study was to determine the role of Xrs2 in Tel1 activation. We found that fusing the Tel1 interaction domain (TID) from Xrs2 to Mre11-NLS (Mre11-NLS-TID) is sufficient to restore telomere elongation and Tel1 signaling to Xrs2-deficient cells. The Mre11-NLS-TID fusion proteins improve Mre11 association with DSBs and further suppress the DNA damage sensitivity of *xrs2Δ* cells. The suppression is dependent on Tel1 but partially independent of the kinase activity, suggesting a structural role of Tel1 in DNA repair. Moreover, *MRE11-NLS xrs2Δ* cells exhibit a severe DNA end-tethering defect and instability of stalled replication forks, which are again rescued by enforcing Tel1 recruitment to the Mre11 complex. Our data suggest a model whereby Xrs2 and Tel1 independently contribute to Mre11 complex stabilization at DSBs and stalled replication forks to promote genome integrity.

RESULTS {#S2}
=======

Enforcing Tel1 Recruitment to the MRX Complex {#S3}
---------------------------------------------

Our previous study showed that *MRE11-NLS xrs2Δ* cells are unable to recruit and activate Tel1 upon DSB formation and are defective for telomere maintenance ([@R47]). In addition, Mre11 enrichment at DSBs is reduced compared to wild-type (WT) cells, similar to a *tel1Δ* mutant ([@R18]). Because Tel1 is required for the normal retention of Mre11 at DSBs, we asked whether enforcing Tel1 recruitment in the absence of Xrs2 could restore Tel1 signaling and stabilize the MR complex at DSBs.

To address these questions, we fused the TID of Xrs2 to the C terminus of Mre11-NLS. A previous study showed that the C-terminal 161 amino acids of Xrs2 are necessary and sufficient for Tel1 interaction ([@R46]); however, the precise TID within the C-terminal fragment of Xrs2 is not strictly defined. In *Schizosaccharomyces pombe* and *Xenopus laevis* Nbs1, a highly conserved FXF/Y motif preceded by an acidic patch of amino acids was shown to be essential for Tel1^ATM^ binding ([@R76]), and a recent study showed that fusing the C-terminal 60 amino acids of *S. pombe* Nbs1 to Mre11 is sufficient to restore Tel1 signaling to Nbs1-deficient cells ([@R34]). *S. cerevisiae* Xrs2 has two such motifs, one located 100 aa from the C terminus and another within the C-terminal 15 aa. For this reason, we constructed Mre11-NLS-TID fusion proteins with two differing lengths of the Xrs2 C terminus: 164 aa, consisting of both FXF motifs, and 85 aa with only the most C-terminal FXF motif ([Figure 1A](#F1){ref-type="fig"}). The *MRE11-NLS-X164* and *MRE11-NLS-X85* constructs were integrated at the leu2 locus on chromosome III with the *MRE11* promoter and 3^′^ UTR sequences in a strain with a deletion of the endogenous *MRE11* locus. Expression of the TID fusion proteins is slightly lower than Mre11, similar to Mre11-NLS ([Figure S1A](#SD1){ref-type="supplementary-material"}). Because a previous study found that a short C-terminal fragment of Xrs2, including the Mre11 binding domain and Tel1 binding domain (residues 630--854), is able to rescue DNA damage sensitivity and partially restore telomere length when expressed in an *xrs2Δ* background ([@R69]), we constructed the same fragment and integrated it into the chromosome with the *XRS2* promoter and 3^′^ UTR sequences (X224) ([Figure 1A](#F1){ref-type="fig"}). In addition, we constructed a derivative of the X224 fragment fused to a MYC epitope to compare steady-state protein levels to full-length Xrs2-MYC; both proteins are expressed at similar levels ([Figure S1B](#SD1){ref-type="supplementary-material"}). There are two predicted NLS sequences in Xrs2, a monopartite NLS at residues 350--360 and a bipartite NLS located at the C terminus (residues 816--849) of the protein (predicted by cNLS Mapper). The fusion proteins and the X224 fragment contain the predicted bipartite and lack the monopartite NLS. The observation that X224 is able to partially complement *xrs2Δ* demonstrates that the predicted bipartite NLS is sufficient for nuclear localization of the MRX complex ([@R69]).

Recruitment of Tel1 to sequences adjacent to the HO endonuclease cut site at the *MAT* locus was measured by chromatin immunoprecipitation (ChIP). In these strains, the galactose-inducible *GAL1--10* promoter regulates expression of the HO endonuclease, and *HML* and *HMR* are deleted to prevent homology-dependent repair of the DSB. Tel1 binding was measured before and 90 min after HO induction. Expression of both of the fusion proteins in the *xrs2Δ* background restores Tel1 enrichment to WT levels, while expression of the X224 fragment only partially suppresses the *xrs2Δ* Tel1 recruitment defect ([Figure 1B](#F1){ref-type="fig"}). Telomeres are restored to WT length in cells expressing the fusion proteins, while the *X224* fragment only partially rescues the short telomere phenotype ([Figure 1C](#F1){ref-type="fig"}). To examine Tel1 activity in response to DNA damage, phosphorylation of the downstream effector kinase Rad53 was measured following acute zeocin treatment. Rad53 is activated by Tel1 bound to MRX at DSBs or by Mec1-Ddc2 associated with replication protein A (RPA)-coated ssDNA generated as a result of end resection. Because the Mec1 pathway is dominant in yeast, it was necessary to use *mec1Δ* strains to detect Rad53 activation by the Tel1 pathway (all of the strains also have an sml1D mutation to suppress lethality caused by *mec1Δ* \[[@R78]\]). Cells expressing the fusion proteins show reduced but visible Rad53 phosphorylation, while Rad53 does not show an obvious mobility shift in cells expressing the *X224* fragment ([Figure 1D](#F1){ref-type="fig"}). These data indicate that fusion of the TID to Mre11-NLS is able to recruit and activate Tel1 in the absence of Xrs2 and that the *X224* fragment has a reduced ability to recruit and activate Tel1 compared to the fusion proteins.

Tel1 Stabilizes Mre11 at DSB Ends and Enhances DNA Damage Resistance in the Absence of Xrs2 {#S4}
-------------------------------------------------------------------------------------------

*MRE11-NLS xrs2Δ* and *tel1Δ* strains show decreased retention of Mre11 at DSBs ([@R6]; [@R18]; [@R47]). To address whether recruiting Tel1 to the MR complex could restore enrichment of Mre11, we measured Mre11 binding to sequences adjacent to the HO cut site by ChIP. Expression of the fusion proteins, as well as the *X224* fragment, in the *xrs2Δ* mutant consistently rescues the defective retention of Mre11 at DSBs ([Figure 2A](#F2){ref-type="fig"}). We were surprised to find that expression of all 3 constructs results in higher Mre11 enrichment than is observed in WT cells. We speculated that the higher level of Mre11 is due to a role for Xrs2 in turnover of the complex. Because the FHA domain is missing in all 3 constructs, we measured Mre11 enrichment in the *xrs2-SH* mutant, which contains mutations of 2 conserved residues within the FHA domain. The xrs2-SH mutant shows a similar increased enrichment of Mre11 to the fusion proteins and the *X224* fragment, suggesting that the FHA domain of Xrs2 plays a role in the eviction of the MRX complex from DSB ends ([Figure 2A](#F2){ref-type="fig"}). Deletion of TEL1 in the *xrs2Δ X224* strain completely abolishes the restoration of Mre11 retention, indicating that Tel1 is responsible for the observed increased enrichment of Mre11 at DSBs ([Figure 2A](#F2){ref-type="fig"}).

The severe genotoxin sensitivity of the *xrs2Δ* mutant is partially suppressed by *MRE11-NLS* ([@R47]; [@R69]). However, at a higher concentration of camptothecin (CPT) or methyl methanesulfonate (MMS), the *MRE11-NLS xrs2Δ* strain shows greatly reduced survival as compared to WT (Figures [2B](#F2){ref-type="fig"} and [S2A](#SD1){ref-type="supplementary-material"}). This result is not due to the combined defects in Tel1 signaling and NHEJ, since the *lif1Δ tel1Δ* double mutant is more resistant to CPT than the *MRE11-NLS xrs2Δ* strain. We hypothesized that the reduced DNA damage resistance of *MRE11-NLS xrs2Δ* cells could be due to failure to maintain Mre11 at DSBs. The *MRE11-NLS-TID xrs2Δ* strains, which show restored Mre11 binding to DSBs, exhibit similar DNA damage resistance to WT cells. The restoration of CPT resistance is dependent on Tel1, but it is partially independent of the Tel1 kinase activity, which is consistent with Tel1 contributing in a structural manner to stabilize Mre11 at DSBs. Because deletion of *TEL1* confers CPT sensitivity only in the absence of *XRS2*, it suggests that Tel1 can compensate for Xrs2 in promoting DNA damage resistance ([Figure 2B](#F2){ref-type="fig"}).

The *X224* fragment also restores DNA damage resistance to WT levels; however, unlike the fusion proteins, the restoration is mostly independent of Tel1 ([Figure 2C](#F2){ref-type="fig"}). This result suggests that the Mre11 binding domain present in the 224-aa Xrs2 fragment but not in the fusion proteins promotes DNA damage resistance in the absence of Tel1. In agreement with our previous study, normal growth and DNA damage resistance of the *xrs2Δ* strains expressing either the Mre11-TID fusions or X224 fragment is dependent on *SAE2* ([Figures S2B and S2C](#SD1){ref-type="supplementary-material"}), indicating that the MR end resection function is critical for proliferation and DNA damage resistance in Xrs2-deficient cells.

Tel1 Rescues the DNA Bridging Defect of *MRE11-NLS xrs2Δ* Cells {#S5}
---------------------------------------------------------------

The finding that restoring Mre11 enrichment at DSBs enhances DNA damage resistance of the *xrs2Δ* mutant prompted us to examine the structural role of the MRX complex in bridging DSB ends and tethering sister chromatids. *In vitro*, MRX is sufficient for end-bridging activity ([@R13]), and the role of Xrs2 in this process has not been investigated. To monitor DSB tethering, we inserted Lac repressor binding site (lacO) and Tet repressor binding site (tetO) arrays on opposite sides of an I-SceI cut site on chromosome V of haploid cells ([Figure 3A](#F3){ref-type="fig"}). In this strain, I-SceI is expressed from a *GAL1--10* promoter, YFP-LacI and TetR-RFP are constitutively expressed, and a Rad52-CFP fusion is used to monitor DSB formation. It is important to note that the DSB is effectively "irreparable": HR cannot be used because I-SceI is expected to cut both sister chromatids in S/G2 phase cells, and imprecise NHEJ to mutate the I-SceI cut site is rare in yeast ([@R10]).

4 hr after I-SceI induction, the DSB can be visualized by appearance of a Rad52-CFP focus that co-localizes with YFP and/or RFP. For a tethered DSB, we cannot distinguish between one and two Rad52 foci ([Figure 3B](#F3){ref-type="fig"}). However, for untethered DSBs, we observe some cells with two Rad52 foci, each associated with RFP or YFP, and others with a Rad52 focus associated with only one end (Figures [3B](#F3){ref-type="fig"} and [S3A](#SD1){ref-type="supplementary-material"}). The distance between YFP and RFP foci was measured in at least 100 cells with co-localizing Rad52 foci. Consistent with previous studies using similar assays, most WT cells exhibit co-localizing YFP and RFP foci ([Figures 3B and 3C](#F3){ref-type="fig"}) ([@R6]; [@R25]; [@R37]; [@R55]). We observe a significant increase in DSB end-to-end separation in *xrs2Δ* cells, and *MRE11-NLS* is unable to rescue this defect. In agreement with previous studies, the *tel1Δ* mutant shows a slight increase in DSB end separation ([@R6]; [@R31]), but in contrast to the [@R31] study, we find comparable end tethering in *tel1-kd* and WT cells ([Figure S3B](#SD1){ref-type="supplementary-material"}). Retention of Mre11 at DSBs is independent of Tel1 kinase activity ([@R18]), correlating with the end-tethering function. As expected if Mre11 retention at DSBs facilitates end tethering, the Mre11-NLS-X85 fusion protein and Xrs2 fragment are able to significantly rescue the end-tethering defect of *xrs2Δ* cells ([Figure 3C](#F3){ref-type="fig"}). The recovery of end tethering in *xrs2Δ MRE11-NLS-X85* cells is Tel1 dependent, while the loss of Tel1 in *xrs2Δ X224* cells reduces end tethering to the same level as observed in the *tel1Δ* mutant. These data mirror the DNA damage resistance of the strains and indicate separable roles of Xrs2 binding to Mre11 and Tel1-mediated stabilization of Mre11-DNA association in promoting end tethering and genotoxin resistance. The enhanced end tethering in *xrs2Δ MRE11-NLS-X85* and *xrs2Δ X224* is partially dependent on the kinase activity of Tel1 ([Figure S3](#SD1){ref-type="supplementary-material"}), suggesting that Tel1 contributes in both a kinase-dependent and -independent manner in these mutant contexts.

In late S and G2 phases, when the sister chromatid is present, the MRX complex also holds sisters together at DSBs ([@R55]). Cells with 2 foci of the same fluorescence indicate sister chromatid separation. The *xrs2Δ* and *MRE11-NLS xrs2Δ* strains show increased sister chromatid separation, which again is rescued by the fusion proteins and *X224* fragment ([Figure 3D](#F3){ref-type="fig"}). These data demonstrate that Tel1 recruitment is crucial to stabilize Mre11 at DSBs to facilitate the DNA bridging function of the complex, especially when Xrs2 is not present. Cohesin, an SMC complex that normally keeps sister chromatids paired during G2 and cell division, also contributes to DSB and stalled replication fork repair, presumably by maintaining sister chromatids in a conformation that favors HR ([@R21]; [@R26]; [@R58]; [@R67]). Mre11 and Tel1 are involved in the recruitment of DNA damage-induced cohesin around DSBs and stalled forks ([@R64]; [@R63]; [@R67]; [@R70], [@R71]). To assess cohesin binding, enrichment of Scc1 (a subunit of the cohesin complex) was measured at sequences 1 kb from an HO-induced DSB at the MAT locus. The reduced Scc1 binding observed in *xrs2Δ* and *xrs2Δ MRE11-NLS* cells is rescued by expression of the fusion protein as well as the *X224* fragment ([Figure 3E](#F3){ref-type="fig"}). This observation suggests that the sister chromatid separation in *xrs2Δ* cells could be due to reduced cohesin recruitment resulting from low enrichment of Mre11 at DSB ends.

End Tethering by MRX Is Not Required for DSB-Induced Recombination {#S6}
------------------------------------------------------------------

Previous studies have suggested that the end-tethering function of MRX is important for NHEJ and HR ([@R6], [@R7]; [@R9]; [@R13]). We tested whether NHEJ is restored in *xrs2Δ* cells expressing the fusion proteins or *X224* fragment because end-to-end tethering is significantly increased in these cells. Using a plasmid-ligation assay, we found that NHEJ is at the same low level in all of the *xrs2Δ* derivatives ([Figure S4A](#SD1){ref-type="supplementary-material"}), indicating that restoration of end tethering is not sufficient for NHEJ. Previous studies have shown that interaction between the Xrs2 FHA domain and Lif1 is required for NHEJ and is likely the reason for low NHEJ in the *xrs2Δ* strains expressing *MRE11-NLS-TID* or *X224* ([@R9]; [@R39]; [@R47]; [@R48]).

Next, we used a direct repeat recombination reporter to determine how end tethering affects DSB-induced HR. In this system, an I-SceI-induced DSB at the *ade2-I* locus is repaired using the intact *ade2-n* allele ([Figure 4A](#F4){ref-type="fig"}) ([@R44]). In *RAD51* cells, repair occurs mainly by gene conversion (GC) maintaining the *TRP1* marker located between the repeats, whereas single-strand annealing (SSA), which results in deletion of TRP1 and 1 of the repeats, is *RAD51* independent. We observe no significant change in *RAD51*-dependent GC or *RAD51*-independent SSA in *MRE11-NLS xrs2Δ* compared to WT ([Figure 4B](#F4){ref-type="fig"}), indicating that end tethering is not required for homology-dependent DSB repair in this context.

Null mutation of genes encoding the MRX complex results in an increased rate of spontaneous recombination between heteroalleles in diploid cells ([@R1]; [@R24]; [@R38]). One mechanism suggested for the hyper-recombination phenotype is by channeling lesions from the sister chromatid to the homolog for repair due to the disruption of sister chromatid tethering ([@R23]; [@R65]). We measured the rate of spontaneous recombination using diploid cells with *ade2-I* and *ade2-n* heteroalleles ([Figure S4B](#SD1){ref-type="supplementary-material"}). Consistent with a previous study, the *xrs2Δ* mutant displays a 5-fold increase in the rate of Ade^+^ recombinants ([@R24]). This phenotype is suppressed by *MRE11-NLS*, indicating that defective sister chromatid tethering is not responsible for the hyper-recombination phenotype ([Figure S4C](#SD1){ref-type="supplementary-material"}). However, when *SAE2* is deleted in this strain, the triple mutant again shows hyper-recombination, suggesting that the hyper-rec phenotype is due to defective end resection, reducing co-conversion of the markers.

Suppression of Chromosome Rearrangements by MRX {#S7}
-----------------------------------------------

Previous studies reported a 600-fold increase in the rate of gross chromosome rearrangements (GCRs) in the absence of MRX ([@R8]). By contrast, loss of Tel1 signaling or Mre11 nuclease activity causes no increase or a modest increase in GCRs, respectively ([@R11]; [@R45]; [@R59]). We measured the spontaneous GCR rate using an assay that detects simultaneous loss of 2 markers on the left arm of chromosome V ([@R8]) ([Figure 4C](#F4){ref-type="fig"}). Consistent with previous studies, the xrs2D mutant shows a 664-fold increase in GCR accumulation compared to WT. *MRE11-NLS* lowers the GCR rate of *xrs2Δ* cells \~16-fold, but this rate is still \~42-fold higher than that observed for WT ([Figure 4D](#F4){ref-type="fig"}). However, expression of the *MRE11-NLS-X85* fusion protein or *X224* fragment in the *xrs2Δ* mutant led to a complete suppression of the hyper-GCR phenotype in a Tel1-dependent manner.

Tel1 Rescues the Stalled Replication Fork Instability of *MRE11-NLS xrs2Δ* Cells {#S8}
--------------------------------------------------------------------------------

We noticed a significant increase in cells with spontaneous Rad52-CFP foci in *xrs2Δ* and *MRE11-NLS xrs2Δ* strains ([Figure 5A](#F5){ref-type="fig"}). This observation, along with the increased rate of GCRs and sensitivity to HU ([Figure 5B](#F5){ref-type="fig"}), suggests more replication-associated DNA damage. The MRX complex is recruited to stalled replication forks and has been shown to stabilize the association of essential replisome components ([@R55]; [@R66]). This function is independent of the S phase checkpoint and the nuclease activity of Mre11, indicating a structural contribution of the complex in stabilizing stalled replication forks ([@R66]). To address whether the DNA bridging function of MRX correlates with the replisome stability function, we measured the presence of Mre11 and DNA polymerase α (Polα) near an early firing origin (*ARS607*) by ChIP after releasing G1 synchronized cells into 0.2 M HU. As anticipated, the strains with DNA tethering defects, *xrs2Δ* and *MRE11-NLS xrs2Δ*, show loss of Mre11 and Pola enrichment compared to WT ([Figure 5C](#F5){ref-type="fig"}). Expression of *MRE11-NLS-X85*, as well as the *X224* fragment, completely rescues Mre11 and Pola enrichment at stalled replication forks and HU sensitivity of xrs2D cells, as well as reducing the number of cells with spontaneous Rad52 foci ([Figures 5A--5C](#F5){ref-type="fig"}). Unlike the response to CPT and MMS, we find that HU resistance of the *xrs2Δ X224* mutant requires Tel1. Therefore, we also measured Pola and Mre11 enrichment at ARS607 in tel1D derivatives. Pola enrichment in tel1D cells is comparable to WT cells, while Mre11 enrichment is reduced, similar to that observed at DSBs. The rescue of Pola enrichment is completely Tel1 dependent in xrs2D MRE11-NLS-X85 cells ([Figure 5C](#F5){ref-type="fig"}), which is consistent with the end-tethering data, suppression of spontaneous Rad52 foci, and GCRs. At the 40-min time point, Polα retention at ARS607 in *xrs2D X224* cells is partially Tel1 dependent, but at 60 min, Pola enrichment is lost in the *tel1Δ* derivative, correlating with GCR results. These data suggest that Tel1 stabilization of Mre11 at stalled forks is important to prevent fork collapse and suppression of GCRs in cells lacking Xrs2.

To visualize replication fork progression in the presence of replicative stress, DNA combing was performed. Genomic DNA obtained from S phase cells pulse labeled with bromodeoxyuridine (BrdU) for 3 hr in the presence of 0.2 M HU were stretched, and newly synthesized DNA tracks were detected with anti-BrdU ([Figure 5D](#F5){ref-type="fig"}). Consistent with the DNA Polα ChIP data, *xrs2Δ* and *MRE11-NLS xrs2Δ* had shorter track lengths compared to WT, which was rescued by the *MRE11-NLS-X85* fusion protein or the *X224* fragment ([Figure 5E](#F5){ref-type="fig"}). Collectively, these data show that loss of MR-mediated end tethering correlates with increased replisome fragility and elevated genomic instability.

DISCUSSION {#S9}
==========

MRX functions in telomere maintenance and DNA damage checkpoint signaling by recruiting and activating the Tel1 kinase. Although the Tel1 binding domain within the C-terminal region of yeast Xrs2/Nbs1 is required for Tel1 activation *in vivo* ([@R46]; [@R76]), ATM activation can occur independently of the C-terminal ATM-interaction domain of mammalian Nbs1 ([@R27]; [@R30]; [@R62]). Moreover, ATP-induced conformational changes to the MR complex are critical for ATM activation ([@R2]; [@R13]; [@R43]; [@R52]). Here, we show that fusing the TID from Xrs2 to Mre11-NLS restores Tel1 activation, supporting the hypothesis that Tel1 recruitment and activation are separate functions of the MRX complex. Our studies further refine the Tel1 binding domain to the last 84 aas of Xrs2, encompassing an acidic patch and FXF/Y motif that were previously shown to be essential for Tel1/ATM signaling in other systems ([@R15]; [@R34]; [@R76]).

Our studies identified a structural role for Tel1 in maintaining the association of Mre11 with DSBs that becomes physiologically relevant in the absence of Xrs2. Previous studies have shown reduced association of Mre11 with DSBs in the *tel1Δ* mutant, but not in cells lacking Tel1 kinase activity ([@R6]; [@R18]; [@R47]). The *tel1Δ* mutant shows far greater resistance to genotoxins than *mre11Δ*, indicating that reduced binding of Mre11 at damage sites does not grossly impair the DNA repair function of Mre11. Nbs1 binding to Mre11 extends the dimer interface and stabilizes the dimeric form of Mre11 ([@R54]). We find that expression of an Xrs2-derived peptide encompassing the Mre11 and Tel1 binding domains is highly effective in suppressing DNA damage resistance and Mre11 retention at DSBs in *xrs2Δ* cells, suggesting that stabilization of the Mre11 dimer is a critical function of Xrs2. Supporting our findings, [@R27] found that expression of a 108-aa fragment of Nbs1, encompassing the Mre11 interaction domain, is sufficient to restore proliferation to Nbs1-deficient murine cells. Our data suggest that Tel1 and Xrs2 independently contribute to Mre11 activity at DNA ends. While loss of Tel1 stabilization alone does not have a strong impact on DNA damage resistance, Tel1 can compensate for Xrs2-mediated Mre11 dimer stabilization to promote repair. The Tel1 stabilization function is critical for HU resistance and suppression of GCRs, even when the Xrs2-Mre11 interaction interface is restored, suggesting an additional function of Xrs2 during replication stress. The murine *Nbs1*^*ΔB/ΔB*^ mutation, which deletes the N-terminal FHA and BRCT domains but retains Mre11 interaction, is synthetically lethal with ATM deficiency, suggesting that compensation between Nbs1 and ATM is conserved in mammals ([@R73]). We propose that the quantity and quality of the MRX complex compensate each other. Optimally stabilized Mre11 complex may engage in sufficient DNA tethering with minimal quantity, while suboptimal complex may exhibit a reduced ability to interact with DNA and thus require a higher local concentration. It remains unclear how Tel1 facilitates Mre11 retention at DSBs because no direct interaction between MR and Tel1 has been reported.

Our findings indicate that Mre11 stabilization at ends is critical for the end-tethering function of MRX, and the previously reported reduction in end tethering of the *tel1Δ* mutant is a consequence of lower retention of Mre11 at DSBs. Retention of Mre11 at DSBs, end tethering, and DNA damage resistance are highly correlated, raising the question of how end tethering facilitates genome integrity. Although end tethering is restored in *xrs2Δ MRE11-NLS-X85* cells, NHEJ remains defective, indicating that end tethering is not sufficient for this mode of repair. Previous studies have suggested that end tethering is important for DSB-induced GC and for SSA ([@R6],[@R7];[@R16]).However, we found both GC and SSA to be restored to WT frequencies in *xrs2Δ MRE11-NLS* cells, which are defective for end tethering. Because the assay that we used measures intrachromatid recombination or recombination between misaligned sister chromatids, we cannot rule out the possibility that MRX bridging is important for precise sister chromatid recombination.

Our data suggest that CPT and MMS sensitivity of *xrs2Δ MRE11-NLS* cells is due to the failure to maintain tethering during DNA replication. Loss of DNA tethering results in more spontaneous Rad52 foci and increased rates of GCRs, which are indicators of replication stress. The strains with reduced end tethering show lower Mre11 association with stalled replication forks, replisome instability, and shorter DNA synthesis tracks in response to replication stress. This phenotype could be caused by the loss of cohesin because a previous study showed that rad50 mutants defective for tethering have reduced cohesin bound at stalled replication forks ([@R67]). We show here that cohesin enrichment mirrors Mre11 enrichment at DSBs, consistent with an important role for MRX in recruitment or maintenance of cohesin at damaged sites. The MR complex is known to associate with chromatin during S phase and co-localizes to stressed and unstressed replication forks ([@R41]; [@R57]; [@R66]). MR could use its intrinsic DNA binding activity to travel with the replisome, to associate with the end produced by fork reversal, or it could be indirectly associated with DNA via RPA interaction ([@R55]). Our data indicate that failure of MR to stably associate with DNA during replication stress results in fork collapse and, ultimately, to chromosome rearrangements.

STAR⋆METHODS {#S10}
============

KEY RESOURCES TABLE {#S11}
-------------------

  REAGENT or RESOURCE                                                                                SOURCE                     IDENTIFIER
  -------------------------------------------------------------------------------------------------- -------------------------- ---------------------------------
  Antibodies                                                                                                                    
  Anti-Mre11                                                                                         [@R28]                     N/A
  Anti-HA tag antibody - ChIP Grade                                                                  Abcam                      Cat\# ab9110; RRID:AB_307019
  Monoclonal ANTI-FLAG® M2 antibody                                                                  Sigma-Aldrich              Cat\# F1804; RRID:AB_262044
  Anti-Rad53                                                                                         M. Foiani                  N/A
  c-Myc (9E10) antibody                                                                              Santa Cruz Biotechnology   Cat\# sc-40; RRID:AB_627268
  V5 tag antibody \[SV5-Pk1\]                                                                        Abcam                      Cat\# ab27671; RRID:AB_471093
  BrdU antibody \[BU1/75 (ICR1)\]                                                                    Abcam                      Cat\# ab6326; RRID:AB_305426
  Anti-DNA, single stranded, clone 16--19 antibody                                                   Millipore                  Cat\# MAB3034; RRID:AB_11212688
  Goat anti-Rat IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 488                         Thermo Fisher              Cat\# A-11006; RRID:AB_2534074
  Bacterial Strains and Plasmids                                                                                                
  NEB 5-alpha Competent *E. coli* (High Efficiency)                                                  NEB                        Cat\# C2987I
  pRG205MX                                                                                           [@R17]                     Addgene 64536
  Chemicals, Peptides, and Recombinant Proteins                                                                                 
  (S)-(+)-Camptothecin                                                                               Sigma-Aldrich              Cat\# C9911
  Methyl methanesulfonate, 99%                                                                       Sigma-Aldrich              Cat\# 129925
  HU, 98%, powder                                                                                    Sigma-Aldrich              Cat\# H8627
  Zeocin Selection Reagent                                                                           Thermo Fisher              Cat\# R25001
  α-Factor Mating Pheromone, yeast                                                                   GenScript                  Cat\# RP01002
  Pronase from *Streptomyces griseus*                                                                Sigma-Aldrich              Cat\# 10165921001
  5-Fluoroorotic Acid Monohydrate (FOA, 5-FOA)                                                       US Biological              Cat\# F5050
  L-Canavanine sulfate salt, ≥ 99% (TLC), powder                                                     Sigma-Aldrich              Cat\# C9758
  Pierce Protein A/G Magnetic Beads                                                                  Thermo Fisher              Cat\# 88803
  SsoAdvanced Universal SYBR® Green Supermix                                                         Bio-rad                    Cat\# 1725271
  Critical Commercial Assays                                                                                                    
  QuikChange II Site-Directed Mutagenesis Kit                                                        Agilent                    Cat\# \#200523
  Experimental Models: Organisms/Strains                                                                                        
  *S. cerevisiae*: Strain background: W303 ([Table S1](#SD1){ref-type="supplementary-material"})     R. Rothstein               N/A
  *S. cerevisiae*: Strain background: S288C ([Table S1](#SD1){ref-type="supplementary-material"})    R. Kolodner                N/A
  Oligonucleotides                                                                                                              
  ChIP-qPCR HO+0.2kb-F: TCGTCTTGCTCTTGTTCCCAATG                                                      This study                 N/A
  ChIP-qPCR HO+0.2kb-R: CATCCGTCCCGTATAGCCAATTC                                                      This study                 N/A
  ChIP-qPCR HO+1kb-F: TGGACGGAGGACTTAATATCGTCAC                                                      This study                 N/A
  ChIP-qPCR HO+1kb-R: AGGATGCCCTTGTTTTGTTTACTG                                                       This study                 N/A
  ChIP-qPCR HO+66kb-F: CGTTACTTTCCTCATCACCTTCGC                                                      This study                 N/A
  ChIP-qPCR HO+66kb-R: ACAGAGAGAGTGGGCTCATCTTGC                                                      This study                 N/A
  ChIP-qPCR ARS607-F: CGGCTCGTGCATTAAGCTTG                                                           This study                 N/A
  ChIP-qPCR ARS607-R: TGCCGCACGCCAAACATTGC                                                           This study                 N/A
  ChIP-qPCR ARS607+14kb-F: CGGCTGTCATGCCAAGATGC                                                      This study                 N/A
  ChIP-qPCR ARS607+14kb-R: CTCTTCATCACTGGAGTCCT                                                      This study                 N/A
  Software and Algorithms                                                                                                       
  Volocity                                                                                           PerkinElmer Inc.           N/A
  AxioVision                                                                                         Zeiss                      N/A
  FIJI (Fiji is just imageJ; v.1.47b)                                                                ImageJ software            N/A
  Other                                                                                                                         
  Leica DM5500B upright microscope with 100x Leica oil-immersion 1.46NA objective                    Leica Microsystems         N/A
  Zeiss Axio Imager 2 microscope equipped with AxioCam MRc and a 63x Zeiss oil-immersion objective   Zeiss                      N/A
  FiberPrep® Molecular Combing System                                                                Genomic Vision             N/A
  CFX384 Touch Real-Time PCR Detection System                                                        Bio-rad                    N/A

CONTACT FOR REAGENT AND RESOURCE SHARING {#S12}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Lorraine Symington (<lss5@cumc.columbia.edu>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S13}
--------------------------------------

*S*. cerevisiae W303 background strains were used for all experiments except for the GCR assay, in which S288C background strains were used. See [Table S1](#SD1){ref-type="supplementary-material"} for genotypes of all the strains used in this study. Media and growth conditions were as described previously ([@R3]). Experiments were carried out with log-phase cells, unless otherwise indicated. Cells were grown at 30°C for all the experiments except for the end tethering assay, in which cells were grown at 23°C.

METHOD DETAILS {#S14}
--------------

### Generation of yeast strains and plasmids {#S15}

For the Mre11-NLS-X164 and Mre11-NLS-X85 strains, overlapping PCR was performed to fuse C-terminal 164 aa and 85 aa fragments of Xrs2 to the C terminus of Mre11-NLS with 5xGly as a linker. The resulting Mre11-NLS-X164 and Mre11-NLS-X85 constructs were cloned into pRG205MX ([@R17]), along with the promoter (450bp upstream) and 3^′^UTR (599bp downstream) of *MRE11*, and were integrated into the *LEU2* locus of *mre11::TRP1* strain. Integration was confirmed by PCR and DNA sequence analysis, and expression of the fusion proteins was analyzed by western blot using α-Mre11 polyclonal antibodies ([@R28]). For the X224 strain, a 224 aa C-terminal fragment of Xrs2 was amplified and cloned into pRG205MX, along with the XRS2 promoter (504bp upstream) and 3^′^UTR (468bp downstream), and was integrated into the *LEU2* locus of an *xrs2::kanMX* strain. X224-MYC strain was constructed by one-step targeting of a PCR fragment containing a sequence encoding 13 repeats of MYC. Derivatives with *tel1Δ*, *tel1-kd* or appropriately tagged proteins were generated by genetic cross ([@R67]; [@R77]). For the end tethering assay strain (W11278--23B), a tandem array of tet operators (tetOx336) was integrated in ura3 on chromosome V, and an I-SceI cut site was integrated 4 kb to the left of ura3 in iYEL023, as described ([@R35]). The tetO array was visualized by TetR-mRFP, which is integrated in the intergenic region iYGL119 on chromosome VII. A tandem array of lac operators (lacOx256) was integrated in iYEL024, 4 kb to the left of the I-SceI cut site. The lacO array was visualized by YFP-LacI integrated in his3. The I-SceI endonuclease gene is under the transcriptional control of *GAL1--10* promoter, integrated in *lys2*. The Rad52 C terminus was tagged with GAx3 linker and yeast codon optimized mTurquoise2, which is an improved variant of CFP. The protein sequence of mTurquoise2 is from ([@R20]) and yeast codon optimization was ordered from GenScript. Integration was accomplished with pop-in, pop-out using *K. lactis URA3*. All other W303-derived strains were obtained from crossing appropriate haploid strains. Strains used for the GCR assay were made by transformation with linear DNA fragments to generate gene disruptions, or to integrate Mre11 or Xrs2 constructs.

### DNA damage sensitivity assays {#S16}

Cells grown overnight were diluted to 0.5 OD~600~. 10-fold serial dilutions were made and were 4 μL were spotted onto media with or without indicated DNA damaging drugs.

### ChIP-qPCR {#S17}

For HA-Tel1, Mre11, and Scc1-PK ChIP at *MAT* locus, cells were grown in YP medium containing 2% lactate (YPL) to log phase. Cells were collected before (-HO) and 90 min after (+HO) addition of galactose to a final concentration of 2% for HO induction. For Polα-Flag and Mre11 ChIP at replication origin *ARS607*, cells were arrested in G1 using α-factor and released into YPD containing 0.2 M HU. Cells were collected at 20 min intervals after release. Collected cells were crosslinked with 1% formaldehyde and were then lysed in lysis buffer (50 mM HEPES, 140 mM NaCl, 1 mM EDTA, 1% IGEPAL CA-630, 0.1% Sodium deoxycholate, 1 mM PMSF) using FastPrep-24 (MP Biomedicals). Chromatin was fragmented by water bath sonication and immuno-precipitation was carried out with protein Pierce A/G magnetic beads coupled to Anti-Mre11 ([@R28]), anti-HA (ab9110), anti-Flag M2 (Sigma), or anti-V5 \[SV5-pk1\] (ab27671) antibodies overnight at 4°C. qPCRs were carried out by the SYBR green system using primer pairs complementary to DNA sequences corresponding to *ARS607* and sites 0.2 kb and 1 kb from the HO-cut site at *MAT*. DNA sequences located 66 kb from *MAT* and 14 kb from *ARS607* were amplified as background controls. Fold enrichment calculations were done as described ([@R47]). Fold enrichment was calculated by 2^ΔΔCq^, where ΔΔCq = (Cq(IP, control) -- Cq(input, control)) -- (Cq(IP, DSB) -- Cq(input, DSB)).

### Telomere blot {#S18}

Genomic DNA was isolated from 5 ml of saturated cultures and digested with XhoI. The products were examined by Southern blot analysis with radioactively labeled pYT14 as a hybridization probe.

### Western blot and Rad53 phosphorylation assay {#S19}

Protein extracts for western blot analysis were prepared by TCA precipitation. Anti-Mre11, anti-Rad53 (gift from M. Foiani), and anti-cMyc 9E10 (Santa Cruz Biotechnology) were used for western blot analysis. For checkpoint activation, cells were collected after 1 hr in a media containing 500 μg/mL of zeocin (Invitrogen).

### End tethering assay {#S20}

Cells were grown to log phase in SC medium containing 2% raffinose at 23°C. Then, galactose was added to a final concentration of 2% for I-SceI induction. Cells were collected and washed after 4 hr of growth at 23°C. Cells were re-suspended in a small volume of SC medium containing 2% glucose and were immobilized on a microscope slide by mixing them with a solution of 1.2% low melting agarose in SC medium. Live cell fluorescent imaging was performed on Leica DM5500B upright microscope with 100x Leica oil-immersion 1.46NA objective, using 100W mercury arc lamp as the light source. Chroma bandpass filter sets were used to visualize RFP (41002c), YFP (41028), and CFP (31044v2). Images were acquired with Hamamatsu ORCA-ER-1394 camera using Volocity software. 14 z sections at 0.3 μm intervals were taken for each channel.

### DNA combing {#S21}

DNA combing was performed as described ([@R68]). Cells were arrested in G1 using α-factor. BrdU was added to a final concentration of 40 μg/ml and 0.2 M HU 15 min before release cells into S phase using 50 mg/ml Pronase. After 3 hr in 30°C, cells were collected and genomic DNA was prepared in 1% low melting point agarose DNA combing was performed on a Combicoverslip with the FiberComb Molecular Combing System (Genomic Vision). BrdU was detected with a rat monoclonal antibody (ab6326) followed by a secondary antibody coupled to Alexa 488 (A11006, Molecular Probes). DNA molecules were detected with an anti-ssDNA antibody (MAB3034) followed by an anti-mouse IgG coupled to Alexa 546 (A11030, Molecular Probes). DNA fibers were analyzed on a Zeiss Axio Imager 2 microscope equipped with AxioCam MRc and a 63x Zeiss oil-immersion objective. Image acquisition was performed with AxioVision software. At least 100 BrdU track lengths were measured for each genotype with ImageJ and representative DNA fibers were assembled with ImageJ.

### GCR assay {#S22}

The rate of GCRs was measured by fluctuation assay as previously described ([@R50]). Cells were grown to saturation and plated on YPD medium, or minimal medium containing 5-floroorotic acid and canavanine (5-FOA Can). Plates were incubated in 30°C and colonies were counted after 3--5 days. Two or more independent experiments using sets of at least five independent cultures were performed.

### Recombination assays {#S23}

The direct repeat recombination assay was performed as previously described ([@R40]; [@R53]). Cells were grown to log phase in synthetic complete medium lacking tryptophan (SC-TRP) supplemented with raffinose and then plated on YPD or 2% galactose (YPGal). Plates were incubated at 30°C and colonies counted after 2--4 days. Colonies from YPGal were replica plated to SC-TRP to determine the fraction due to GC. Cell viability after I-SceI induction was determined by dividing the number of Trp^+^ and Trp^--^ colonies on YPGal by that on YPD. For the diploid recombination assay, cells were grown to log phase and plated on YPD or SC-ADE. Plates were incubated at 30°C and colonies counted after 3--4 days. A fluctuation assay was used to determine the heteroallelic recombination rate.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S24}
---------------------------------------

Quantification and statistical analysis were done using PRISM (GraphPad). The ChIP-qPCR experiments were performed at least two times and statistical significance was determined by a two-tailed Student's t test. For the end-tethering assay, at least 100 cells were used for each genotype and statistical significance was determined by a two-tailed Student's t test. ns = not significant p ≥ 0.05, \*p ≤ 0.05, \*\*\*p ≤ 0.001, \*\*\*\*p ≤ 0.0001. For DNA combing, at least 100 individual BrdU track lengths were measured and statistical significance was determined by Mann-Whitney rank sum test. \*\* p ≤ 0.01, \*\*\* p ≤ 0.001. For the GCR and recombination assays, significance was determined by a two-tailed Student's t test. For the GCR assay, at least two independent experiments using sets of at least five independent cultures were performed. For the direct repeat recombination assay, three independent trials were performed. For the diploid recombination assay, three independent trials using eight cultures were performed. For ChIP-qPCR, GCR, and recombination assays, error bars indicate standard deviation. For DNA combing, the box indicates the 25--75-percentile range and whiskers indicate 10--90-percentile range. Vertical bars indicate median values. Statistical details of experiments can also be found in the figure legends and [Method Details](#S14){ref-type="sec"}.
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![Enforcing Recruitment and Activation of Tel1 in *xrs2Δ* Cells\
(A) Schematic representation of Xrs2 protein binding domains and the C-terminal fragments used in this study. FHA, forkhead-associated domain; MID, Mre11 interaction domain; TID, Tel1 interaction domain.\
(B) Schematic representation of the *MAT* locus used in ChIP experiments. The orange bar indicates the region amplified by qPCR. ChIP-qPCR for HA-Tel1 0.2 kb from an HO-induced DSB at the *MAT* locus in cells before (HO) or 90 min after HO induction (+HO). The error bars indicate SD (n = 3).\
(C) Southern blot of XhoI-digested genomic DNA hybridized with a Y' element probe for analysis of telomere lengths. Schematic representation of the telomeric Y' elements and TG repeats. *XhoI* digestion yield a terminal fragment of \~1.3 kb in WT strains.\
(D) Model of Rad53 phosphorylation (Rad53-P) in response to DNA damage. Tel1/ATM responds to MRX/N bound DSBs, whereas Mec1/ATR is activated by RPA bound to the ssDNA formed at resected DSBs. Western blot analysis showing Rad53-P in response to 1 hr of zeocin (500 μg/mL) treatment.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1514161-f0002){#F1}

![Tel1 Promotes Stable Binding of Mre11 to DSBs and Enhances DNA Damage Resistance\
(A) ChIP-qPCR for Mre11 0.2 kb from the HO-induced DSB. The error bars indicate SD (n = 3).\
(B) Tenfold serial dilutions of the indicated strains were spotted onto rich medium with or without CPT at the indicated concentrations. Images were taken after2 days growth (no drug and 1 μg/ml CPT) or 3 days growth on 5 μg/ml CPT.\
(C) Tenfold serial dilutions of the indicated strains were spotted onto rich medium with or without CPT.\
See also [Figure S2](#SD1){ref-type="supplementary-material"}.](nihms-1514161-f0003){#F2}

![Tel1 Promotes the DNA Bridging Function of the Mre11-Rad50 Complex\
(A) Schematic representation of the DSB end-tethering assay system.\
(B) Examples of cells with YFP and RFP foci that are together or separated 4 hr after I-SceI induction.\
(C) Distribution of the distance between YFP and RFP foci. Red lines indicate median values. Cells in G2/M with Rad52 foci were scored (n ≥100). \*\*p ≤ 0.001, \*\*\*\*p ≤ 0.0001.\
(D) Sister chromatid separation after DSB formation and image of a cell with 2 YFP foci, indicating sister chromatid separation. Graph shows the percentage ofcells with either 2 YFP or 2 RFP foci. Cells in G2/M were scored (n ≥ 100). \*p ≤ 0.05, \*\*p ≤ 0.01.\
(E) ChIP-qPCR for Scc1-PK 1 kb from the HO-induced DSB. The error bars indicate SD (n = 2).\
See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms-1514161-f0004){#F3}

![End Tethering Is Required to Suppress GCRs\
(A) Schematic of the ade2 direct repeat recombination reporter. Repair of the I-SceI induced DSB occurs mostly by gene conversion, with no accompanying crossover retaining *TRP1*. *SSA*, an *RAD51*-independent process, results in loss of 1 of the repeats and the intervening *TRP1* marker.\
(B) The frequencies of DSB-induced GC and SSA repair for the indicated strains. Error bars indicate SD (n = 3). ns, not significant (p ≥ 0.05).\
(C) Schematic of the GCR assay. Simultaneous loss of *URA3* and *CAN1* (selected by growth of cells on medium containing 5-fluoroorotic acid \[5-FOA\] and canavanine) is due to the loss of the terminal chromosome region followed by telomere addition, interstitial deletion, and non-reciprocal translocation of hairpin-mediated inverted duplication.\
(D) GCR rates measured by simultaneous loss of *CAN1* and *URA3*. Error bars indicate 95% confidence interval (n ≥ 10).\
See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms-1514161-f0005){#F4}

![Tel1 Promotes the Stalled Replication Fork Stability in *MRE11-NLS xrs2Δ* Cells\
(A) Percentage of cells with a spontaneous Rad52 focus (n ≥ 100).\
(B) Tenfold serial dilutions of the indicated strains spotted onto YPD medium with or without HU at indicated concentration.\
(C) ChIP-qPCR for Polα-FLAG and Mre11 at early firing origin ARS607 following release of cells from G1 arrest into medium containing 0.2 M HU. The error bars indicate SD (n ≥ 2).\
(D) Representative DNA fibers after combing and detection of BrdU tracks (green). Genomic DNA was obtained from S phase cells labeled for 3 hr with BrdU in thepresence of 0.2 M HU.\
(E) Distribution of BrdU track lengths in HU-treated cells. Box: 25th--75th percentile range. Whiskers: 10th--90th percentile range. Vertical bars indicate medianvalues. \*\*p ≤ 0.01, \*\*\*p ≤ 0.001.](nihms-1514161-f0006){#F5}

###### Highlights

-   Xrs2 is required for recruitment but not for activation of Tel1 kinase

-   Tel1 and Xrs2 function independently to optimize MR activity

-   Stable association of Mre11 at DSBs is required to maintain end-to-end tethering

-   MR-mediated DNA tethering promotes replisome stability and genome integrity
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